{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Like&page=26", "query": { "intervention": "Like", "page": 26 }, "page_size": 10 }, "pagination": { "page": 26, "page_size": 10, "total_count": 2537, "total_pages": 254, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Like&page=27&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Like&page=25&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-24T05:56:53.668Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05344859", "title": "GODART Pilot and Feasibility", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Weekly Automated Health Coaching", "type": "BEHAVIORAL" }, { "name": "Weekly Human Health Coaching", "type": "BEHAVIORAL" }, { "name": "Adapted Reward Level", "type": "BEHAVIORAL" }, { "name": "Fixed Gamified Reward Level", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 88, "start_date": "2023-05-15", "completion_date": "2025-10-31", "has_results": false, "last_update_posted_date": "2025-12-17", "last_synced_at": "2026-10-24T05:56:53.668Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT05344859" }, { "nct_id": "NCT03632759", "title": "Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "Liraglutide", "type": "DRUG" }, { "name": "Golimumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Carla Greenbaum, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 16, "start_date": "2018-08-15", "completion_date": "2021-11-09", "has_results": false, "last_update_posted_date": "2022-01-24", "last_synced_at": "2026-10-24T05:56:53.668Z", "location_count": 2, "location_summary": "Idaho Falls, Idaho • Seattle, Washington", "locations": [ { "city": "Idaho Falls", "state": "Idaho" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT03632759" }, { "nct_id": "NCT00686075", "title": "A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-old Children and in 2 Month-old Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "MEDI-534, Cohort 1", "type": "BIOLOGICAL" }, { "name": "Placebo, Cohort 1", "type": "OTHER" }, { "name": "MEDI-534, Cohort 2", "type": "BIOLOGICAL" }, { "name": "Placebo, Cohort 2", "type": "OTHER" }, { "name": "MEDI-534, Cohort 3", "type": "BIOLOGICAL" }, { "name": "Placebo, Cohort 3", "type": "OTHER" }, { "name": "MEDI-534, Cohort 4", "type": "BIOLOGICAL" }, { "name": "Placebo, Cohort 4", "type": "OTHER" }, { "name": "MEDI-534, Cohort 5", "type": "BIOLOGICAL" }, { "name": "Placebo, Cohort 5", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "MedImmune LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Months", "maximum_age": "23 Months", "sex": "ALL", "summary": "2 Months to 23 Months" }, "enrollment_count": 1338, "start_date": "2008-06", "completion_date": "2012-08", "has_results": true, "last_update_posted_date": "2014-09-26", "last_synced_at": "2026-10-24T05:56:53.668Z", "location_count": 51, "location_summary": "Mobile, Alabama • Bentonville, Arkansas • Little Rock, Arkansas + 44 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Bentonville", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00686075" }, { "nct_id": "NCT06847165", "title": "Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Fetal Alcohol Spectrum Disorders", "Attention Deficit Hyperactivity Disorder" ], "interventions": [ { "name": "Trigeminal Nerve Stimulation (TNS)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "8 Years to 12 Years" }, "enrollment_count": 30, "start_date": "2025-04-26", "completion_date": "2026-09-30", "has_results": false, "last_update_posted_date": "2026-07-16", "last_synced_at": "2026-10-24T05:56:53.668Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06847165" }, { "nct_id": "NCT04893265", "title": "Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccination", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Educational Activities" ], "interventions": [ { "name": "Text Messaging Only", "type": "BEHAVIORAL" }, { "name": "INFORMED", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 247, "start_date": "2021-09-30", "completion_date": "2024-06-30", "has_results": true, "last_update_posted_date": "2025-05-14", "last_synced_at": "2026-10-24T05:56:53.668Z", "location_count": 3, "location_summary": "Fresno, California • San Francisco, California • San Jose, California", "locations": [ { "city": "Fresno", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Jose", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04893265" }, { "nct_id": "NCT02130401", "title": "Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "TNM Device", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Scion NeuroStim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 6, "start_date": "2014-06", "completion_date": "2015-06", "has_results": true, "last_update_posted_date": "2025-06-06", "last_synced_at": "2026-10-24T05:56:53.668Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02130401" }, { "nct_id": "NCT06935695", "title": "Surveillance Versus Bronchoscopy After Airway Stenting", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bronchial Stents" ], "interventions": [ { "name": "Bronchoscopy", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2025-01-01", "completion_date": "2026-03-31", "has_results": false, "last_update_posted_date": "2025-04-20", "last_synced_at": "2026-10-24T05:56:53.668Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06935695" }, { "nct_id": "NCT02608853", "title": "Estimation of Malignancy Rates Within Humedica Patient Populations Sampled to be Representative of Liraglutide Initiators and LEADER™ Trial Participants", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Diabetes", "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "No treatment given", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 9999, "start_date": "2015-01", "completion_date": "2015-01", "has_results": false, "last_update_posted_date": "2015-11-20", "last_synced_at": "2026-10-24T05:56:53.668Z", "location_count": 1, "location_summary": "Princeton, New Jersey", "locations": [ { "city": "Princeton", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02608853" }, { "nct_id": "NCT04839198", "title": "Using Machine Learning to Develop Just-in-Time Adaptive Interventions for Smoking Cessation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Smoking Cessation" ], "interventions": [ { "name": "Android Wear smartwatch", "type": "BEHAVIORAL" }, { "name": "Adaptive Treatment", "type": "BEHAVIORAL" }, { "name": "Nicotine Patch", "type": "DRUG" }, { "name": "interviewing-based counseling", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL", "DRUG" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2024-02-06", "completion_date": "2024-11-22", "has_results": false, "last_update_posted_date": "2025-03-28", "last_synced_at": "2026-10-24T05:56:53.668Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04839198" }, { "nct_id": "NCT07202247", "title": "Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Carcinoma", "Recurrent Prostate Carcinoma" ], "interventions": [ { "name": "Antiandrogen Therapy", "type": "DRUG" }, { "name": "Behavioral Intervention", "type": "BEHAVIORAL" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Cardiac Computerized Tomographic Angiography", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Electronic Health Record Review", "type": "OTHER" }, { "name": "Internet-Based Intervention", "type": "OTHER" }, { "name": "Lifestyle Counseling", "type": "BEHAVIORAL" }, { "name": "Medical Device Usage and Evaluation", "type": "OTHER" }, { "name": "Nutritional Intervention", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Radiation Therapy", "type": "RADIATION" }, { "name": "Referral", "type": "OTHER" }, { "name": "Semaglutide", "type": "DRUG" }, { "name": "Short-Term Fasting", "type": "OTHER" }, { "name": "Tirzepatide", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BEHAVIORAL", "PROCEDURE", "OTHER", "RADIATION" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "79 Years", "sex": "MALE", "summary": "30 Years to 79 Years · Male only" }, "enrollment_count": 60, "start_date": "2025-11-05", "completion_date": "2028-04-09", "has_results": false, "last_update_posted_date": "2026-08-17", "last_synced_at": "2026-10-24T05:56:53.668Z", "location_count": 1, "location_summary": "Duarte, California", "locations": [ { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07202247" } ] }